查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1949817

双胍类药物全球市场报告（2026年）

Biguanides Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，双胍类药物市场持续扩张，预计将从2025年的51.1亿美元成长到2026年的52.8亿美元，复合年增长率为3.4%。过去几年的成长可归因于第2型糖尿病盛行率的上升、人们对代谢性疾病认识的提高、非专利双胍类药物的供应增加、口服降血糖药的普及以及肝臟标靶治疗方法的进步。

预计未来几年双胍类药物市场将稳定成长，到2030年市场规模将达到59.7亿美元，复合年增长率（CAGR）为3.1%。预测期内的成长要素包括：对个人化医疗的需求不断增长、远端医疗在糖尿病照护中的应用、卵巢症候群（PCOS）发病率的上升、联合治疗的研发以及政府促进慢性病管理的倡议。预测期内的主要趋势包括：个人化糖尿病管理方案、联合治疗的研发、适应症范围扩大至第2型糖尿病以外、居家医疗和远端患者监护以及价格合理的非专利双胍类药物。

糖尿病盛行率的不断上升预计将推动双胍类药物市场的扩张。糖尿病是一种慢性代谢性疾病，其特征是由于胰岛素分泌不足或胰岛素作用受损而导致的高血糖。糖尿病患者数量的快速增长归因于生活方式的改变、人口老化以及诊断技术进步带来的公众意识的提高。双胍类药物可透过提高胰岛素敏感性、抑制肝臟葡萄糖生成以及帮助降低第2型糖尿病患者的血糖值，从而有助于糖尿病的治疗。例如，根据英国政府机构－健康改善和消除不平等办公室（OHID）发布的数据，截至2024年3月，完成全部八项建议护理步骤的1型糖尿病患者比例较2022年3月至2023年3月增长了22%，2型糖尿病患者的比例增长了21%。此外，达到糖化血红素（HbA1c）目标水准的患者比例也达到了创纪录的37.9%。因此，糖尿病盛行率的不断上升正在推动双胍类药物市场的成长。

双胍类药物市场的主要企业正优先开发创新解决方案，例如缓释双胍类製剂，旨在提高患者依从性、优化血糖控制并减少消化器官系统副作用。缓释双胍类製剂旨在随着时间的推移逐渐释放活性成分，从而稳定血中浓度、提高耐受性并增强糖尿病管理的长期依从性。例如，2023年8月，印度食品药物管理局瑞迪博士实验室（Dr. Reddy's Laboratories）推出了沙格列汀和盐酸二甲双胍的缓释片。本产品是美国FDA核准的KOMBIGLYZE XR（DPP-4抑制剂沙格列汀和二甲双胍的复方製剂）的学名药替代品。它为第2型糖尿病成人患者提供了一种便捷的每日一次给药选择，可与饮食和运动相结合，辅助血糖控制。其缓释机制也有助于提高患者的依从性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球双胍类药物市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 个人化糖尿病管理解决方案
    • 联合治疗研发
    • 将适应症扩展到第 2 型糖尿病以外
    • 居家医疗和远端患者监护
    • 经济实惠的通用非专利药物

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 零售药房
  • 网路药房
  • 糖尿病护理中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球双胍类药物市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球双胍类药物市场规模、对比及成长率分析
  • 全球双胍类药物市场表现：规模与成长，2020-2025年
  • 全球双胍类药物市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按类型
  • 二甲双胍、苯乙双胍和其他类型
  • 按剂型
  • 锭剂，口服液
  • 配方
  • 速释、缓释
  • 透过分销管道
  • 医院药局、零售药局、网路药局
  • 按类型细分：二甲双胍
  • 速释二甲双胍，缓释二甲双胍
  • 按类型细分：苯乙双胍
  • 盐酸苯乙双胍
  • 按类型细分：其他类型
  • 二甲双胍和丁福明组合药物

第十章 区域与国家分析

  • 全球双胍类药物市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球双胍类药物市场：按国家/地区划分，实际数据和预测数据，2020-2025年、2025-2030年预测数据、2035年预测数据

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 双胍类药物市场：竞争格局及市场占有率（2024年）
  • 双胍类药物市场：公司估值矩阵
  • 双胍类药物市场：公司概况
    • Pfizer Inc.
    • Sanofi-Aventis LLC
    • Viatris Inc.
    • Aurobindo Pharma Ltd.
    • Cipla Ltd

第37章：其他领先和创新企业

  • Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 双胍类药物市场展望 2030：提供新机会的国家
  • 双胍类药物市场展望 2030：新兴细分市场机会
  • 双胍类药物市场2030年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: PH5MBIGU01_G26Q1

Biguanides are a class of drugs mainly prescribed for type 2 diabetes treatment. They reduce blood sugar by decreasing hepatic glucose production and enhancing insulin sensitivity. These drugs also manage polycystic ovary syndrome (PCOS) and various metabolic conditions.

The primary biguanides include metformin, phenformin, and several others. Metformin stands out as a commonly prescribed biguanide drug for managing type 2 diabetes by reducing blood glucose levels. It comes in multiple dosage forms, such as tablets and oral solutions, available in options like immediate-release and extended-release, and is distributed through channels including hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have affected the biguanides market by increasing the cost of imported raw materials and active pharmaceutical ingredients (APIs), leading to higher production costs and potential delays in supply chains. Regions like Asia-Pacific, which are major manufacturing hubs for biguanides, are most impacted, particularly for metformin and extended-release formulations. Hospital and retail pharmacy segments may face temporary price increases, while local manufacturers might benefit from protective measures, encouraging domestic production and reducing dependency on imports. Overall, the tariffs have a mixed impact, creating challenges in cost management but potential incentives for local manufacturing.

The biguanides market research report is one of a series of new reports from The Business Research Company that provides biguanides market statistics, including biguanides industry global market size, regional shares, competitors with a biguanides market share, detailed biguanides market segments, market trends and opportunities, and any further data you may need to thrive in the biguanides industry. This biguanides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biguanides market size has grown steadily in recent years. It will grow from $5.11 billion in 2025 to $5.28 billion in 2026 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to increasing prevalence of type 2 diabetes, rising awareness of metabolic disorders, growth in generic biguanides availability, adoption of oral antidiabetic medications, advancements in liver-targeted therapies.

The biguanides market size is expected to see steady growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 3.1%. The growth in the forecast period can be attributed to growing demand for personalized medicine, expansion of telemedicine for diabetes care, rising incidence of pcOS, development of combination therapies, government initiatives promoting chronic disease management. Major trends in the forecast period include personalized diabetes management solutions, combination therapy development, expanded indications beyond type 2 diabetes, home healthcare & remote patient monitoring, cost-effective generic biguanides.

The increasing prevalence of diabetes is anticipated to drive expansion in the biguanides market. Diabetes represents a chronic metabolic condition marked by high blood glucose levels resulting from inadequate insulin production or ineffective insulin action. This surge in diabetes stems from shifts in lifestyle, an aging population, and greater awareness through diagnostics. Biguanides aid in managing diabetes by enhancing insulin sensitivity, curbing glucose output from the liver, and assisting in blood sugar reduction for those with type 2 diabetes. For instance, in March 2024, data from the Office for Health Improvement & Disparities (OHID), a UK government body, showed that from March 2022 to March 2023, the share of type 1 diabetes patients completing all eight recommended care processes rose by 22%, with a 21% increase for type 2 diabetes, and the percentage meeting target HbA1c levels hit 37.9%-the highest on record. Thus, the growing incidence of diabetes is fueling biguanides market growth.

Major companies in the biguanide market are prioritizing the development of innovative solutions like extended-release biguanide formulations to boost patient compliance, optimize glycemic control, and reduce gastrointestinal side effects. Extended-release biguanide formulations are medications engineered to release their active ingredient slowly over time, ensuring steady blood levels, better tolerability, and stronger long-term adherence for people managing diabetes. For example, in August 2023, Dr. Reddy's Laboratories, an India-based biotech firm, introduced saxagliptin and metformin hydrochloride extended-release tablets-a USFDA-approved generic equivalent of KOMBIGLYZE XR that pairs saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide-providing adults with type 2 diabetes a convenient once-daily option that aids glycemic control alongside diet and exercise, while its extended-release mechanism promotes greater adherence.

In August 2023, Lupin, an India-based biopharmaceutical firm, purchased the diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim for an undisclosed sum. This deal bolsters Lupin's standing in the anti-diabetes market by broadening its lineup with proven oral antidiabetic treatments. It also boosts the company's capacity to enhance patient access to vital diabetes drugs and solidifies its rivalry in the metabolic disorders sector. Boehringer Ingelheim, a Germany-based biopharmaceutical firm, focuses on researching, developing, and manufacturing therapies for human and veterinary use.

Major companies operating in the biguanides market are Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biguanides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biguanides market consists of sales of Chlorhexidine, Polyhexanide, Proguanil, and Buformin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biguanides Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biguanides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biguanides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biguanides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Metformin; Phenformin; Other Types
  • 2) By Dosage Form: Tablets; Oral Solutions
  • 3) By Formulation: Immediate Release; Extended Release
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Subsegments:
  • 1) By Metformin: Immediate-Release Metformin; Extended-Release Metformin
  • 2) By Phenformin: Phenformin Hydrochloride
  • 3) By Other Types: Buformin; Metformin Combinations
  • Companies Mentioned: Pfizer Inc.; Sanofi-Aventis LLC; Viatris Inc.; Aurobindo Pharma Ltd.; Cipla Ltd; Dr. Reddy's Laboratories; Lupin Limited; Zydus Lifesciences Limited; Torrent Pharmaceuticals Limited; Intas Pharmaceuticals Ltd.; Apotex Inc; Sun Pharmaceutical Industries Ltd.; Glenmark Pharmaceuticals Ltd.; Mylan Laboratories Ltd.; Teva Pharmaceutical Industries Ltd.; Alkem Laboratories Ltd.; Panacea Biotech Ltd.; Wanbury Ltd; USV Private Limited; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Biguanides Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Biguanides Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Biguanides Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Biguanides Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Sustainability, Climate Tech & Circular Economy
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Personalized Diabetes Management Solutions
    • 4.2.2 Combination Therapy Development
    • 4.2.3 Expanded Indications Beyond Type 2 Diabetes
    • 4.2.4 Home Healthcare & Remote Patient Monitoring
    • 4.2.5 Cost-Effective Generic Biguanides

5. Biguanides Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Retail Pharmacies
  • 5.4 Online Pharmacies
  • 5.5 Diabetes Care Centers

6. Biguanides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biguanides Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Biguanides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Biguanides Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Biguanides Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Biguanides Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biguanides Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biguanides Market Segmentation

  • 9.1. Global Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metformin, Phenformin, Other Types
  • 9.2. Global Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tablets, Oral Solutions
  • 9.3. Global Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immediate Release, Extended Release
  • 9.4. Global Biguanides Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
  • 9.5. Global Biguanides Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immediate-Release Metformin, Extended-Release Metformin
  • 9.6. Global Biguanides Market, Sub-Segmentation Of Phenformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Phenformin Hydrochloride
  • 9.7. Global Biguanides Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Buformin, Metformin Combinations

10. Biguanides Market Regional And Country Analysis

  • 10.1. Global Biguanides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Biguanides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biguanides Market

  • 11.1. Asia-Pacific Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biguanides Market

  • 12.1. China Biguanides Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biguanides Market

  • 13.1. India Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biguanides Market

  • 14.1. Japan Biguanides Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biguanides Market

  • 15.1. Australia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biguanides Market

  • 16.1. Indonesia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biguanides Market

  • 17.1. South Korea Biguanides Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biguanides Market

  • 18.1. Taiwan Biguanides Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biguanides Market

  • 19.1. South East Asia Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biguanides Market

  • 20.1. Western Europe Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biguanides Market

  • 21.1. UK Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biguanides Market

  • 22.1. Germany Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biguanides Market

  • 23.1. France Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biguanides Market

  • 24.1. Italy Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biguanides Market

  • 25.1. Spain Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biguanides Market

  • 26.1. Eastern Europe Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biguanides Market

  • 27.1. Russia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biguanides Market

  • 28.1. North America Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biguanides Market

  • 29.1. USA Biguanides Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biguanides Market

  • 30.1. Canada Biguanides Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biguanides Market

  • 31.1. South America Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biguanides Market

  • 32.1. Brazil Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biguanides Market

  • 33.1. Middle East Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biguanides Market

  • 34.1. Africa Biguanides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biguanides Market Regulatory and Investment Landscape

36. Biguanides Market Competitive Landscape And Company Profiles

  • 36.1. Biguanides Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Biguanides Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Biguanides Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Aurobindo Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Cipla Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Biguanides Market Other Major And Innovative Companies

  • Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

38. Global Biguanides Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biguanides Market

40. Biguanides Market High Potential Countries, Segments and Strategies

  • 40.1 Biguanides Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Biguanides Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Biguanides Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer